Don Teater MD Medical Advisor National Safety Council Itasca, IL Medical Provider Behavioral Health Group Asheville, NC Medical Provider Meridian Behavioral.

Slides:



Advertisements
Similar presentations
Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Advertisements

Late Stabilization & Maintenance Phase of Treatment.
Dosing and patient management requirements during induction, stabilization, and detoxification with buprenorphine Matthew A. Torrington MD Clinical Research.
Swinomish Wellness Program
Sublingual Buprenorphine and Pain
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
Your Medicine: Play it Safe. Your Health Care Team Doctors, nurse practitioners, and other medical professionals Nurses Pharmacists Use the link below.
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module III – Buprenorphine 101.
Medication Assisted Therapy for Opioid Addiction: Methadone and Buprenorphine Andrew J. Saxon, M.D. Veterans Affairs Puget Sound Health Care System and.
OPIOID SUBSTITUTION THERAPY
Module V: Coordinated Care BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Substance Use & Abuse in Pregnancy Janet L. Mitchell, M.D., M.P.H., F.A.C.O.G. Consultant on Women’s Health Addiction Research & Treatment Corporation.
Promoting the Use of Injectable Naltrexone (Vivitrol) in Colorado Staff Training, Patient Screening, Medication Administration, and Payor Source Development.
Dr. Avinash De Sousa.  State government aided hospital.  Private psychiatric set up – nursing home.  Out patient private practice.  Private general.
Pain Management Laura Bergs FNP. Definition of Chronic Pain Anyone with pain greater than 3 months Anyone with pain greater than 3 months Pain An unpleasant.
Module V – Coordinated Care BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Opioid Use in Workers’ Compensation Suzanne Novak, MD, PhD November 2008.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Problem Behaviors Norman Wetterau. Less serious Ran of out pills three days early After one year lost pills Had a headache and a friend gave her a vicodin.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Tom Waddell Urban Health Clinic: Patients Using Controlled Medicines* If you are taking controlled medicines, your safety is our highest priority! Our.
Efficacious Physician-Patient Relationships Or Physician, Therapist and Patient Relationships Elliot S. Cohen, M. D. M. L. Grabill, M.Ed. PsychiatristLicensed.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.
Buprenorphine {Suboxone®, Subutex®}
Don Teater MD Medical Advisor National Safety Council Medical Provider Mountain Area Recovery Center Asheville, NC Medical Provider Meridian Behavioral.
Implementing a Urine Drug Screening Protocol to Teach Appropriate Opioid Prescribing in a Residency Practice STFM Annual Conference May 2, 2016 Nata Young,
Vivitrol (Naltrexone) Treatment for opioid addiction.
Benjamin J. Pariser, DO RASE Physician.  This presentation will review the option of Medication Assisted Treatment as part of a comprehensive recovery.
Introduction to Suboxone What Family Physicians Can Offer Friday April 15th, 2016 John L Bender, MD, MBA,FAAFP.
Medication Assisted Treatment for Opioid Use Disorders
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
Medications for the Treatment of Opioid Addiction Robert P. Schwartz, M.D. Friends Research Institute.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
December 10, 2015 Arthur Robin Williams MD MBE American Academy of Addiction Psychiatry Division on Substance Abuse Department of Psychiatry, Columbia.
Presented by Caroline Waterman, MA, LRC, CRC, Executive Director, COMPA Sonia Lopez, MD, Medical Director, START Sarah Church, Ph.D., Executive Director,
CDC Guideline for Prescribing Opioids for Chronic Pain- United States-2016 Gisele J. Girault, M.D. First Choice Healthcare Columbia, SC.
Addressing the issue: Prescription Drug Misuse in North Carolina
Gregory S. Brigham, Ph.D., CEO
Medication Assisted Treatment
Current Concepts in Pain Management
Examining Potential Misuse of Gabapentin Among Patients Admitted to an Inpatient Behavioral Health Unit Samuel Kubas a, Pharm.D. Candidate 2018; Lucas.
Buprenorphine Agreement
Opioid Medication Assisted Tx (1)
Center of Excellence Kate Henry LCSW, CCDPD Stacey Burroughs, LPC, CAADC Behavioral Health Service Line May 15th 2017.
Medication-Assisted Therapy at Coleman Profession Services
Caldwell County Narcotic Initiative
Place name sticker or stamp with card
Opioids – A Pharmaceutical Perspective on Prescription Drugs
Opioid Prescribing & Monitoring
Controlled substance compliance
Appropriate Opiate Prescribing: Managing Chronic Pain in a FQHC
Medication-Assisted Treatment 101: Breaking the Stigma
Barbara Allison-Bryan, MD
Prescriber-Friendly Buprenorphine Delivery Model
Prescription Drug Monitoring Program
Ten Pearls for Medication Assisted Treatment of Opiate Use Disorders
Re-bundling Medically Assisted Treatment
Prescription Drug Monitoring Program
Opioid prescribing workflow in the electronic medical record.
Medically assisted treatment
Medication Assisted Treatment of Opioid Use Disorder
Treating Opioid Use Disorder
Treatment of Opioid Use Disorder
Harm Reduction Approach to Treatment of All Substance Use Disorders
Ann Cox, DNP, FNP-BC, PMHNP-BC
Tapering and Discontinuing Chronic Opioid Therapy
Treat Opioid USE DISORDER like the chronic disease it is
Presentation transcript:

Don Teater MD Medical Advisor National Safety Council Itasca, IL Medical Provider Behavioral Health Group Asheville, NC Medical Provider Meridian Behavioral Health Services Waynesville, NC

Background Board certified Family Physician in a solo family practice in the southern Appalachian Mountains since In the early 2000s I began to see more patients who were addicted to prescription opioid medications. In 2004 I took the DATA 2000 training to prescribe buprenorphine. –That changed my life more than anything else that I have done in medicine!

Our system 1.Initial phone call/screen 2.Secondary screen by CMA or nurse 3.Initial physician visit 4.One-day follow-up 5.One week follow-up 6.Ongoing visits every 4 weeks.

Initial phone call Initial screen when they call for admission for treatment. –Why do you think you need treatment? –What drugs are you taking and how often?

Secondary screen For the secondary screen, they come in and meet with a CMA. –Review of all drugs they are taking Prescribed Illicit –Brief past medical history –Sign consent for us to talk with primary care doctor and all prescribing doctors –Sign treatment agreement Example at: –Schedule initial visit with me. Inform them that they MUST be in withdrawal. IR opioids: None for 24 hours ER opioids: None for 48 hours Methadone: None for 3 or more days –Do a urine drug screen now!

1 st visit with physician Is buprenorphine appropriate? Determine that the patient does have OUD. –PDMP –UDS Do H&P. Is buprenorphine/naloxone the best choice for them? –Consider also methadone (at an OTP) or naltrexone injection (Vivitrol®)

1 st visit with physician Initiation Determine that they are in withdrawal –Restless –Rhinorrhea –Diaphoretic –Pupils dilated –Tachycardic –Tremor Give initial dose and wait 1 hour then recheck. –Completely safe and often dramatic Give rx for 2-4 pills and send them home.

Day 2 follow-up How did they do overnight? Did they take any extra? Calculate daily dose, give 1 week rx, schedule f/u in 1 week.

Buprenorphine/naloxone Always use the combination product (unless pregnant)! Allergy to naloxone is extremely rare!

Week 1 follow-up How have they done on the prescribed dose? Develop a plan for counseling or groups If doing well then f/u in 4 weeks.

Recheck q 4 weeks Discuss dose Cravings? Any drug use? Other addictions (nicotine)? Social situation? Any signs of withdrawal? Pupil size Alertness Check PDMP (in your state and neighbor states if they are close by) UDS This can be charged as a visit.

Pearls A dose higher than 16 mg per day is seldom necessary Encourage patients to take their dose once a day in the morning Drug screening should be done at every visit but can be done randomly when the patient is stable and doing well.

Pearls Trust nobody! –Have a system where people are randomly called back for pill counts and witnessed UDS. –Occasionally check for buprenorphine/norbuprenophine in the urine.

Pearls Addiction is a disease. –Some will need to be on MAT the rest of their lives –There will be relapses

Resources TIP 40 – SAMHSA (Its free!) Guide for treatment of OUD with bupe. Buprenorphine-in-the-Treatment-of-Opioid-Addiction/SMA Buprenorphine-in-the-Treatment-of-Opioid-Addiction/SMA Treatment agreement: Clinical Opioid Withdrawal Scale: Efficacy of pain medications: Other NSC resources: Go to nsc.org and click on “Learn” then “Prescription Painkillers”.nsc.org My